179 related articles for article (PubMed ID: 36056404)
1. Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study.
Ghazala E; Shahin DA; Wahba Y
Ital J Pediatr; 2022 Sep; 48(1):157. PubMed ID: 36056404
[TBL] [Abstract][Full Text] [Related]
2. Single-Base Gene Variants in
Buainain RP; Sodré AR; Dos Santos JS; Takazaki KAG; Queiroz LS; de Oliveira CTP; de Aguiar PHP; Marson FAL; Ortega MM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892194
[TBL] [Abstract][Full Text] [Related]
3. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
[TBL] [Abstract][Full Text] [Related]
5. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
[TBL] [Abstract][Full Text] [Related]
6. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
[TBL] [Abstract][Full Text] [Related]
7. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
8. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
9. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Zhang X; Liu J; Ye J
Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
[TBL] [Abstract][Full Text] [Related]
10. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
11. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.
Abe T; Seo T; Ishitsu T; Nakagawa T; Hori M; Nakagawa K
Br J Clin Pharmacol; 2008 Aug; 66(2):304-7. PubMed ID: 18489610
[TBL] [Abstract][Full Text] [Related]
12. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
[TBL] [Abstract][Full Text] [Related]
13. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
[TBL] [Abstract][Full Text] [Related]
15. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
16. [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy].
Huang J; Qian Z; Chen H; Huang Q; Huang L; Liu G; Tang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Mar; 36(3):271-274. PubMed ID: 30835363
[TBL] [Abstract][Full Text] [Related]
17. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
18. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
[TBL] [Abstract][Full Text] [Related]
19. Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients.
Margari L; Legrottaglie AR; Vincenti A; Coppola G; Operto FF; Buttiglione M; Cassano A; Bartolomeo N; Mariggiò MA
Seizure; 2018 Feb; 55():30-35. PubMed ID: 29353705
[TBL] [Abstract][Full Text] [Related]
20. The lack of influence of IVS5-91 G>A polymorphism of the SCN1A gene on efficacy of lamotrigine in patients with focal epilepsy.
Markovic I; Pejanovic-Skobic N; Bozina N; Susak Sporis I; Sporis D; Basic S
Neurol Res; 2019 Oct; 41(10):930-935. PubMed ID: 31256750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
